129822-45-3

Basic information

• Product Name: 4-Fluoro-N-(BOC)-indole
• Synonyms: 4-Fluoro-N-(BOC)-indole;1H-Indole-1-carboxylic acid;tert-butyl 4-fluoro-1H-indole-1-carboxylate
• CAS NO: 129822-45-3
• Molecular Formula: C13H14FNO2
• Molecular Weight: 235.2541632
• Mol File: 129822-45-3.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-Fluoro-N-(BOC)-indole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Fluoro-N-(BOC)-indole(129822-45-3)
• EPA Substance Registry System: 4-Fluoro-N-(BOC)-indole(129822-45-3)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1 / PGIII
• Hazardous Substances Data: 129822-45-3(Hazardous Substances Data)

Usage

General Description

4-Fluoro-N-(BOC)-indole is a chemical compound that is commonly used in various forms of research. This chemical is extensively used in the production of pharmaceuticals and in various chemical reactions in laboratories. Its molecular formula is C14H14FN2O2, and its molecular weight is 266.27. 4-Fluoro-N-(BOC)-indole contains fluorine and its protective BOC group can be removed under acidic conditions. 4-Fluoro-N-BOC-indole is a light-yellow crystalline solid in its natural state and should be stored in a cool, dry condition to retain its properties. This chemical is classified as disastrous for the environment; therefore, proper handling and waste management protocols must be followed.

Upstream product

• 138343-91-6 4-Fluoro-2-hydroxy-2,3-dihydro-indole-1-carboxylic acid tert-butyl ester 
• 387-43-9 4-fluoroindole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 443-86-7 3-fluoro-2-methylaniline 
• 129822-38-4 tert-butyl (3-fluoro-2-methylphenyl)carbamate 
• 1195931-67-9 tert-butyl 4-(((trifluoromethyl)sulfonyl)oxy)-1H-indole-1-carboxylate 
• 1000068-25-6 (1-(tert-butoxycarbonyl)-4-fluoro-1H-indol-2-yl) boronic acid 
• 188057-26-3 6-chloro-2-iodopyridine-3-ol 

Downstream Products

• 1000068-25-6 (1-(tert-butoxycarbonyl)-4-fluoro-1H-indol-2-yl) boronic acid 
• 1427034-54-5 2-chloro-11-fluoro-6-phenyl-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indole 
• 1427034-58-9 2-(3-(benzyloxy)-6-chloropyridin-2-yl)-4-fluoro-1H-indole 
• 1440543-49-6 6-(2-(benzyloxy)ethyl)-2-chloro-11-fluoro-12,12a-dihydro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indole 
• 1427034-87-4 6-(2-(benzyloxy)ethyl)-2-chloro-11-fluoro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indole 
• 1427033-93-9 5-(11-fluoro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(2-oxopyrrolidin-1-yl)benzofuran-3-carboxamide 
• 1427033-96-2 5-(11-fluoro-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(2-oxooxazolidin-3-yl)benzofuran-3-carboxamide 
• 1621886-97-2 5-(11-fluoro-6-((methylsulfonyl)methyl)pyrido[3',2’:4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1621886-99-4 5-(6-amino-11-fluoropyrido[3',2':4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1621887-02-2 5-(11-fluoro-6-methyl-5,6-dihydropyrido[3',2':4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1621887-01-1 (S)-5-(11-fluoro-6-methyl-5,6-dihydropyrido[3',2':4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1621887-00-0 (R)-5-(11-fluoro-6-methyl-5,6-dihydropyrido[3',2':4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1621887-24-8 5-(11-fluoro-6-((3-fluoroazetidin-1-yl)methyl)pyrido[3',2':4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)furo[2,3-b]pyridine-3-carboxamide 
• 1621887-30-6 5-(11-fluoro-6-(1-(3-fluoroazetidin-1-yl)ethyl)pyrido[3',2’:4,5]pyrimido[1,6-a]indol-2-yl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 

Relevant articles and documents

Five-membered heterocyclic oxo carboxylic acid compound and medical application thereof

The invention relates to a five-membered heterocyclic oxo carboxylic acid compound and a medical application thereof. Specifically, the invention relates to a compound, a pharmaceutical salt, a prodrug, a hydrate, a solvate or a crystal form as shown in a formula (I), and also relates to a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the pharmaceutical composition as a secretion regulator of interferon type I, especially as an STING agonist in preparation of medicines for preventing and/or treating I-type interferon related diseases.

An entry to 2-(cyclobut-1-en-1-yl)-1: H -indoles through a cyclobutenylation/deprotection cascade

A transition-metal-free strategy for the synthesis of 2-(cyclobut-1-en-1-yl)-1H-indoles under mild conditions is described herein. A series of substituted 2-(cyclobut-1-en-1-yl)-1H-indoles are accessed by a one-pot cyclobutenylation/deprotection cascade from N-Boc protected indoles. Preliminary experimental and density functional theory calculations suggest that a Boc-group transfer is involved in the underlying mechanism.

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. I